Exercise ameliorates renal cell apoptosis in chronic kidney disease by intervening in the intrinsic and the extrinsic apoptotic pathways in a rat model

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Kuan Chou ^a,b   Peng, Chiung Chi ^c   Hsieh, Chiu Lan ^d   Peng, Robert Y ^e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CALPAIN; CASPASE 12; CASPASE 3; CASPASE 8; CASPASE 9; CHOLESTEROL; DOXORUBICIN; FAS ANTIGEN; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PROTEIN BAX; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENDOPLASMIC RETICULUM STRESS; ERYTHROCYTE COUNT; KIDNEY CELL; LEUKOCYTE COUNT; MALE; NICK END LABELING; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RAT; RAT MODEL; SINGLE DRUG DOSE; THROMBOCYTE COUNT; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84885411163     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/368450     Document Type: Article

References (37)

1. Dirks J., Remuzzi G., Horton S., Schieppati A., Rizvi S. A. H., Jamison D. T., Disease control Priorities in developing countries. Diseases of the Kidney and the Urinary System 2006 2nd chapter 36 695 706
2. Hostetter T. H., Chronic kidney disease predicts cardiovascular disease. The New England Journal of Medicine 2004 351 13 1344 1346 2-s2.0-4544249175 (Pubitemid 39258430)
3. National Kidney Foundation, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. American Journal of Kidney Diseases 2002 39 supplement 1 S1 S266
4. Servais H., Ortiz A., Devuyst O., Denamur S., Tulkens P. M., Mingeot-Leclercq M.-P., Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 2008 13 1 11 32 2-s2.0-38049139423 10.1007/s10495-007-0151-z
5. Dhanasekaran A., Gruenloh S. K., Buonaccorsi J. N., Zhang R., Gross G. J., Falck J. R., Patel P. K., Jacobs E. R., Medhora M., Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. American Journal of Physiology-Heart and Circulatory Physiology 2008 294 2 H724 H735 2-s2.0-39149128273 10.1152/ajpheart.00979.2007 (Pubitemid 351253284)
6. Peng C.-C., Chen K. C., Lu H. Y., Peng R. Y., Treadmill exercise improved adriamycin-induced nephropathy. Journal of Biological Regulators and Homeostatic Agents 2012 26 1 15 28 2-s2.0-84859913755
7. Bronas U. G., Exercise training and reduction of cardiovascular disease risk factors in patients with chronic kidney disease. Advances in Chronic Kidney Disease 2009 16 6 449 458 2-s2.0-70349556364 10.1053/j.ackd.2009.07.005
8. Clyne N., The importance of exercise training in predialysis patients with chronic kidney disease. Clinical Nephrology 2004 61 1 S10 S13 2-s2.0-2942746783 (Pubitemid 38787348)
9. Johansen K. L., Painter P., Exercise in individuals with CKD. American Journal of Kidney Diseases 2012 59 1 126 134 2-s2.0-83655161353 10.1053/j.ajkd.2011.10.008
10. Mustata S., Groeneveld S., Davidson W., Ford G., Kiland K., Manns B., Effects of exercise training on physical impairment, arterial stiffness and health-related quality of life in patients with chronic kidney disease: a pilot study. International Urology and Nephrology 2011 43 4 1133 1141 2-s2.0-84859554150
11. Moningka N. C., Sindler A. L., Muller-Delp J. M., Baylis C., Twelve weeks of treadmill exercise does not alter age-dependent chronic kidney disease in the Fisher 344 male rat. Journal of Physiology 2011 589 24 6129 6138 2-s2.0-83455259508 10.1113/jphysiol.2011.214569
12. Astier A., Doat B., Ferrer M.-J., Benoit G., Fleury J., Rolland A., Leverge R., Enhancement of Adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells. Cancer Research 1988 48 7 1835 1841 2-s2.0-0023924788
13. Okuda S., Oh Y., Tsuruda H., Onoyama K., Fujimi S., Fujishima M., Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney International 1986 29 2 502 510 2-s2.0-0022573901 (Pubitemid 16129061)
14. Lee V. W., Harris D. C., Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology 2011 16 1 30 38 2-s2.0-78650643890 10.1111/j.1440-1797.2010.01383.x
15. Toyama K., Sugiyama S., Oka H., Sumida H., Ogawa H., Exercise therapy correlates with improving renal function through modifying lipid metabolism in patients with cardiovascular disease and chronic kidney disease. Journal of Cardiology 2010 56 2 142 146 2-s2.0-77956012193 10.1016/j.jjcc.2010.06.007
16. Pechter Ü., Ots M., Mesikepp S., Zilmer K., Kullissaar T., Vihalemm T., Zilmer M., Maaroos J., Beneficial effects of water-based exercise in patients with chronic kidney disease. International Journal of Rehabilitation Research 2003 26 2 153 156 2-s2.0-0037972743 (Pubitemid 36819942)
17. Kwak H.-B., Song W., Lawler J. M., Exercise training attenuates age-induced elevation in Bax/Bcl-2 ratio, apoptosis, and remodeling in the rat heart. The FASEB Journal 2006 20 6 791 793 2-s2.0-33646259974 10.1096/fj.05-5116fje (Pubitemid 46671217)
18. Fussenegger M., Bailey J. E., Varner J., A mathematical model of caspase function in apostosis. Nature Biotechnology 2000 18 768 774 (Pubitemid 30460695)
19. Bagci E. Z., Vodovotz Y., Billiar T. R., Ermentrout G. B., Bahar I., Bistability in apoptosis: roles of Bax, Bcl-2, and mitochondrial permeability transition pores. Biophysical Journal 2006 90 5 1546 1559 2-s2.0-33646124974 10.1529/biophysj.105.068122
20. Cory S., Huang D. C. S., Adams J. M., The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003 22 53 8590 8607 2-s2.0-0142117313 10.1038/sj.onc.1207102 (Pubitemid 38028528)
21. Gotoh T., Endo M., Oike Y., Endoplasmic reticulum stress-related inflammation and cardiovascular diseases. International Journal of Inflammation 2011 2011 8 259462 10.4061/2011/259462
22. Kawakami T., Inagi R., Wada T., Tanaka T., Fujita T., Nangaku M., Indoxyl sulfate inhibits proliferation of human proximal tubular cells via endoplasmic reticulum stress. American Journal of Physiology-Renal Physiology 2010 299 3 F568 F576 2-s2.0-77956453961 10.1152/ajprenal.00659.2009
23. Szegezdi E., Molecular mechanism of ER stress-induced cell death. NUI Galway Home, OÉ Gaillimh, 2011, http://www.nuigalway.ie/faculties- departments/biochemistry/staff/samali/lab/EvaSzegezdi.html
24. Cybulsky A. V., Endoplasmic reticulum stressin proteinuric kidney disease. Kidney International 2010 77 3 187 193 2-s2.0-74449085963 10.1038/ki.2009.389
25. Nakagawa T., Yuan J., Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis. Journal of Cell Biology 2000 150 4 887 894 2-s2.0-0034698878 10.1083/jcb.150.4.887 (Pubitemid 30663424)
26. Fischer H., Koenig U., Eckhart L., Tschachler E., Human caspase 12 has acquired deleterious mutations. Biochemical and Biophysical Research Communications 2002 293 2 722 726 2-s2.0-0036294646 10.1016/S0006-291X(02)00289- 9 (Pubitemid 34687247)
27. Breckenridge D. G., Germain M., Mathai J. P., Nguyen M., Shore G. C., Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 2003 22 53 8608 8618 2-s2.0-0346250162 10.1038/sj.onc.1207108 (Pubitemid 38019196)
28. Morishima N., Nakanishi K., Takenouchi H., Shibata T., Yasuhiko Y., An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. Journal of Biological Chemistry 2002 277 37 34287 34294 2-s2.0-0037072937 10.1074/jbc.M204973200
29. Rao R. V., Castro-Obregon S., Frankowski H., Schuler M., Stoka V., Rio G. D., Bredesen D. E., Michael Ellerby H., Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. Journal of Biological Chemistry 2002 277 24 21836 21842 2-s2.0-0037077254 10.1074/jbc.M202726200 (Pubitemid 34952336)
30. Rao R. V., Hermel E., Castro-Obregon S., Del Rio G., Ellerby L. M., Ellerby H. M., Bredesen D. E., Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. Journal of Biological Chemistry 2001 276 36 33869 33874 2-s2.0-0035823579 10.1074/jbc.M102225200
31. Rao R. V., Peel A., Logvinova A., Del Rio G., Hermel E., Yokota T., Goldsmith P. C., Ellerby L. M., Ellerby H. M., Bredesen D. E., Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Letters 2002 514 2-3 122 128 2-s2.0-18344388462 10.1016/S0014-5793(02)02289-5 (Pubitemid 34273925)
32. Rutishauser J., Spiess M., Endoplasmic reticulum storage diseases. Swiss Medical Weekly 2002 132 17-18 211 222 2-s2.0-0037018773 (Pubitemid 34733671)
33. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B. A., Yuan J., Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid- β Nature 2000 403 6765 98 103 2-s2.0-0034610743 10.1038/47513 (Pubitemid 30038529)
34. Saleh M., Mathison J. C., Wolinski M. K., Bensinger S. J., Fitzgerald P., Droin N., Ulevitch R. J., Green D. R., Nicholson D. W., Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006 440 7087 1064 1068 2-s2.0-33646175602 10.1038/nature04656
35. Liao P.-C., Tan S.-K., Lieu C.-H., Jung H.-K., Involvement of endoplasmic reticulum in paclitaxel-induced apoptosis. Journal of Cellular Biochemistry 2008 104 4 1509 1523 2-s2.0-46949109986 10.1002/jcb.21730 (Pubitemid 351961719)
36. Nagata S., Apoptosis by death factor. Cell 1997 88 3 355 365 2-s2.0-0030892234 10.1016/S0092-8674(00)81874-7 (Pubitemid 27131377)
37. Schmitz I., Walczak H., Krammer P. H., Peter M. E., The two CD95 apoptosis signalling pathways may be a way of cells to respond to different amounts and/or forms of CD95 ligand produced in different tissues. Cell Death and Differentiation 2000 7 8 756 758 2-s2.0-0033886517 (Pubitemid 30599257)